Michael Saylor: Bitcoin Will Shatter Financial Modelsby John Darbie 15.06.2024Michael Saylor hails Bitcoin as a disruptive force, predicts outdated models will fall. Urges investors to “Join the Swarm” as ...
Bitcoin Forecast: Potential Drop to $48,000 Loomsby John Darbie 15.06.2024Bitcoin forecasts grow bleak with analysts predicting significant price drops amid slowing growth. Join 'Read to Earn' for crypto rewards.
Roaring Kitty’s $262M in GameStop: Market Manipulation?by Mark Eisenberg 15.06.2024Exploring market manipulation and the evolving nature of meme stocks; questioning if Roaring Kitty has become the new Goliath amidst ...
India’s Cryptocurrency Boom: Trends, Trading & WazirX Insightsby John Darbie 15.06.2024Explore the vast potential of India's crypto market with WazirX, a leading exchange. Join Cointribune's 'Read to Earn' program for ...
Smart Tech & Purring Cats: Mastering Stress Managementby Lilu Anderson 15.06.2024A purring cat can alleviate stress, offering a glimpse of a world with optimal stress management, fostering harmony and reducing ...
BlockDAG’s X1 Miner Surge; Optimism’s $OP Dips Amid Whale Sell-Offby John Darbie 15.06.2024Optimism’s $OP token faces a 4.2% dip due to whale sell-off but boasts a $50.20K daily presale, peaking at $3M. ...
Investing in Israeli Tech: A Zionist Opportunity Amid Crisisby Mark Eisenberg 15.06.2024Israel's start-ups battered by war; 80% affected, 50% struggling with cash. Cukierman's platform offers hope as co-investments falter.
Madrigal Pharma Exec Sells $570K in Stock Amid Analyst Focusby Mark Eisenberg 15.06.2024Waltermire sells 2,000 shares at $285 each, netting $570K; Madrigal Pharmaceuticals sees mixed analyst reports with H.C. Wainwright lowering its ...
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
Tempus AI Raises $410M in IPO, Sees Revenue Surgeby Mark Eisenberg 15.06.2024Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...